Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Adel Zhang"'
Autor:
Saba R. Aliyari, Amir Ali Ghaffari, Olivier Pernet, Kislay Parvatiyar, Yao Wang, Hoda Gerami, Ann-Jay Tong, Laurent Vergnes, Armin Takallou, Adel Zhang, Xiaochao Wei, Linda D. Chilin, Yuntao Wu, Clay F. Semenkovich, Karen Reue, Stephen T. Smale, Benhur Lee, Genhong Cheng
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 12, Iss 4, Pp 1624-1635 (2022)
SARS-CoV-2 is an emerging viral pathogen and a major global public health challenge since December of 2019, with limited effective treatments throughout the pandemic. As part of the innate immune response to viral infection, type I interferons (IFN-I
Externí odkaz:
https://doaj.org/article/478f8bc3c0c24622b4fbbf7fef87f486
Autor:
Saba R. Aliyari, Amir Ali Ghaffari, Olivier Pernet, Kislay Parvatiyar, Yao Wang, Hoda Gerami, Ann-Jay Tong, Laurent Vergnes, Armin Takallou, Adel Zhang, Xiaochao Wei, Linda D. Chilin, Yuntao Wu, Clay F. Semenkovich, Karen Reue, Stephen T. Smale, Benhur Lee, Genhong Cheng
Publikováno v:
Acta pharmaceutica Sinica. B, vol 12, iss 4
SARS-CoV-2 is an emerging viral pathogen and a major global public health challenge since December of 2019, with limited effective treatments throughout the pandemic. As part of the innate immune response to viral infection, type I interferons (IFN-I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a0b0c8058d6d895860454797b0ea708
https://pubmed.ncbi.nlm.nih.gov/35251918
https://pubmed.ncbi.nlm.nih.gov/35251918